| # | Drug | Count |
|---|---|---|
| 0 | POMALIDOMIDE | 31 |
| 1 | BORTEZOMIB | 10 |
| 2 | DEXAMETHASONE | 10 |
| 3 | DEXAMETHASONE 1.5 MG | 10 |
| 4 | MIRVETUXIMAB SORAVTANSINE | 8 |
| 5 | MITOMYCIN | 8 |
| 6 | GENTAMICIN SULFATE | 4 |
| 7 | PREDNISOLONE | 4 |
| 8 | PREDNISOLONE ORAL | 4 |
| 9 | PREDNISOLONE ORAL SOLUTION | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MIRVETUXIMAB SORAVTANSINE | 8 | 0.0044 |
| 1 | NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005% | 3 | 0.0031 |
| 2 | MITOMYCIN | 8 | 0.0022 |
| 3 | CYSTEAMINE HYDROCHLORIDE | 1 | 0.0015 |
| 4 | I. V. FAT EMULSION | 1 | 0.0014 |
| 5 | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | 1 | 0.0012 |
| 6 | SODIUM HYALURONATE | 1 | 0.0012 |
| 7 | BESIFLOXACIN | 1 | 0.0010 |
| 8 | NETARSUDIL | 2 | 0.0010 |
| 9 | TOBRAMYCIN AND DEXAMETHASONE | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thalidomide Analog [EPC] | 32 |
| 1 | Corticosteroid [EPC] | 19 |
| 2 | Proteasome Inhibitor [EPC] | 10 |
| 3 | Alkylating Drug [EPC] | 8 |
| 4 | Prostaglandin Analog [EPC] | 6 |
| 5 | Aromatase Inhibitor [EPC] | 4 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 4 |
| 7 | Azole Antifungal [EPC] | 3 |
| 8 | Osmotic Laxative [EPC] | 3 |
| 9 | Aminoglycoside Antibacterial [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 1 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |
| 2 | Sulfone [EPC] | 2 | 0.0002 |
| 3 | Cannabinoid [EPC] | 1 | 0.0001 |
| 4 | Carbonic Anhydrase Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Antimalarial [EPC] | 1 | 0.0001 |
| 6 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 7 | Proteasome Inhibitor [EPC] | 10 | 0.0001 |
| 8 | Prostaglandin Analog [EPC] | 6 | 0.0001 |
| 9 | Thalidomide Analog [EPC] | 32 | 0.0001 |